Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
melatonin (1 trial)
Blindness (Phase 2)
Parasomnias (Phase 2)
Sleep Disorders, Circadian Rhythm (Phase 2)
Sleep Wake Disorders (Phase 2)
Trials (1 total)
Trial APIs (1 total)